ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

NCI Chief Operating Officer Lawrence Ray To Retire

April 24, 2009

In Brief: Baltimore Resigns as Rockefeller President; Perry Named Medical Director At Ellis Fischel

December 13, 1991

New Law Allows Texans To Self-Refer To M.D. Anderson

December 1, 1995

Otis Brawley To Succeed Harmon Eyre As American Cancer Society’s Chief Medical Officer.

August 3, 2007

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013